Robert Dishman

Chief Executive Officer at

Molecular Recognition, Inc.

81 year

33 connections

Health Technology

Commercial Services

Consumer Services

Profile

Robert A. Dishman was the founder of Serenex, Inc. (founded in 2000) where he held the title of Chief Executive Officer & Director from 2000 to 2002, and BioFlash Partners LLC (founded in 2007) where he held the title of Director from 2011 to 2012.
Currently, he is the President & Chief Executive Officer at Molecular Recognition, Inc. since 2002.
Previously, he worked as Director & Executive Vice President at Dyax Corp.
from 1994 to 2000.
He also served as an Independent Director at Harvard Bioscience, Inc. from 2000 to 2015.
Additionally, he held positions as Director at BioSystem Development LLC, Tarpon Biosystems, Inc., and Advisor at Echelon Ventures.
He was also the Executive Vice President-Supply Chain at Nextlife, Inc. Dr. Dishman earned a doctorate degree from the University of Massachusetts and an undergraduate degree from the University of New Hampshire.

Robert Dishman active positions

Companies	Position	Start
Molecular Recognition, Inc.	Chief Executive Officer	01/01/2002

All active positions of Robert Dishman

Former positions of Robert Dishman

Companies	Position	End
HARVARD BIOSCIENCE, INC.	Director/Board Member	28/04/2015
Echelon Ventures Echelon Ventures Investment ManagersFinance Echelon Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements.	Private Equity Investor	30/08/2008
Serenex, Inc. Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs	Founder	01/01/2002
DYAX CORP.	Chief Executive Officer	01/08/1995
Tarpon Biosystems, Inc. Tarpon Biosystems, Inc. BiotechnologyHealth Technology Develops BioSMB systems	Director/Board Member	-

See the detail of Robert Dishman's experience

Training of Robert Dishman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Dishman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Dyax Corp. Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics	Health Technology
Harvard Bioscience, Inc. Harvard Bioscience, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets apparatus and scientific instruments	Health Technology
Serenex, Inc. Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs	Health Technology
BioSystem Development LLC BioSystem Development LLC Miscellaneous Commercial ServicesCommercial Services Provides and designs biotechnology and life science research services and applications	Commercial Services
BioFlash Partners LLC BioFlash Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides bio technical research services	Commercial Services
Tarpon Biosystems, Inc. Tarpon Biosystems, Inc. BiotechnologyHealth Technology Develops BioSMB systems	Health Technology
Echelon Ventures Echelon Ventures Investment ManagersFinance Echelon Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements.	Finance
University of Massachusetts University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of New Hampshire University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nextlife, Inc. Nextlife, Inc. Miscellaneous Commercial ServicesCommercial Services Provides environmental consulting services	Commercial Services
Molecular Recognition, Inc.